Research Article
The Diagnostic Value of 18F-FDG PET/CT in Association with Serum Tumor Marker Assays in Breast Cancer Recurrence and Metastasis
Table 1
Suspected and confirmed malignant foci of CITs and PET/CT.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Confirmation of positive cases was done based on recurrence of cancer as indicated by CITs, pathology, and/or clinical follow-up. Confirmation of negative cases was done based on absence of abnormality as indicated by CITs, repeated PET/CT imaging as well as clinical follow-up for a period of 6 months. |